Access full content on the Portfolio Adviser site, access your saved articles, control email preferences and amend your account details
Equities | 4 Nov 19
‘I have read that Woodford changed his style. I do not agree’
Investment | 3 Oct 18
US Growth trust can hold up to 50% in unlisted securities
Equities | 16 Aug 18
Woodford Patient Capital Trust research note says 9% fall in NAV is ‘small beer’
Equities | 22 Jun 18
Neil Woodford has seen his stake in an unquoted cancer treatment company jump $35.4m in his investment trust as it announces pricing on its initial public offering.
Sign Up for Portfolio Adviser Daily Newsletter
SPONSORED BY Natixis Investment Managers
HEAD-TO-HEAD: Axa versus Fidelity
The FSA Spy market buzz – 15 Nov...
Hermes focuses on price
US in the news: Wealth managers ...
Canadian independent financial a...
Income drawdown jumps 99% in fiv...